Ipsos Health Division - Thought-Leadership Media Pack
It is the role of Business Intelligence to help Pharma continue to grow in these turbulent times. At Ipsos Health, we differentiate ourselves on our `thought-leadership' and ability to provide pharma with a more holistic understanding of the critical issues impacting on the global healthcare sector, both through the market research we undertake and our presence within public and private sector debate.
As the shoots of economic growth are just starting to show globally, there are a number of events in 2010 that may have a long term effect on the pharmaceutical market. These include the reform agenda in the US and cost containment measures in other markets, notably the UK which faces a potential change of government, and a large deficit to cover. In addition, the continual issue of imbalance between innovation and loss of patent has an impact on the growth potential of pharmaceutical companies.
It is the role of Business Intelligence to help Pharma continue to grow in these turbulent times. At Ipsos Health, we differentiate ourselves on our ‘thought-leadership’ and ability to provide pharma with a more holistic understanding of the critical issues impacting on the global healthcare sector, both through the market research we undertake and our presence within public and private sector debate.
We have enclosed a selection of recently published articles in this area. We hope that you enjoy reading them. If you require further information then please do not hesitate to get in touch.
